Application Note: Identifying COVID-19 Vaccine Epitopes Using Peptide Based T cell Activation Assays

As a global pandemic, COVID-19 has completely uprooted our way of life due to the devastating effects of its infection. The race to find an efficacious vaccine has begun the top priority for top pharmaceutical companies all over the world. With these daunting studies, it is important that researchers can find reliable peptides for their T-cell activation assays. The fast moving efforts of better understanding immune response to COVID 19 and vaccine development is needed to combat the current crisis. In particular peptide production is a roadblock that can be overcome by a range of different methods including outsourcing and better bioinformatics tools.

By working together, researchers and clinicians will find a viable vaccine to prevent SARS-CoV-2 infection so future generations do not have to suffer from this terrible illness.